A Phase I/II Study on Safety AND Immunogenicity of AZD4117 and AZD5315 Vaccines (PANDA)
Clinical trial NCT07128615 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07128615
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-04
- Primary completion
- 2026-01-28
- Enrollment
- 405
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.